PROVECTUS BIOPHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Provectus Biopharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$956K, a 33.8% decline year-over-year.
  • Provectus Biopharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$2.8M, a 5.96% increase year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$2.9M, a 15.4% increase from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$3.43M, a 26.6% increase from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$4.67M, a 5.87% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.9M +$527K +15.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$3.43M +$1.24M +26.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$4.67M +$291K +5.87% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$4.96M +$1.34M +21.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$6.3M +$1.75M +21.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$8.05M +$5.27M +39.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$13.3M +$11.2M +45.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$24.5M +$142K +0.58% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 -$24.7M -$12M -95.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$12.6M +$395K +3.03% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-31
2013 -$13M +$1.31M +9.14% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
2012 -$14.3M +$7.1M +33.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$21.4M -$748K -3.61% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 -$20.7M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.